Renumathy Dhanasekaran

20PUBLICATIONS
108CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesRespiratory diseasesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 27, 2026
A Novel Niclosamide Sulfate Prodrug with Enhanced Bioavailability Suppresses Hepatocellular Carcinoma via Inhibition of Multiple Signaling Pathways.

|Jan 06, 2026
Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis.

Gupse Adali, Sencan Acar, Murat Harputluoğlu

|Oct 29, 2024
Practical approach to diagnose and manage benign liver masses.

Reshma Reguram, Aishwarya Ghonge, Justin Tse

|Sep 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease.

Lea Lemaitre, Nia Adeniji, Akanksha Suresh

|Feb 01, 2024
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.

Anja Deutzmann, Delaney K Sullivan, Renumathy Dhanasekaran

|Jun 10, 2023
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making.

Renumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre

Pageof 4

Frequent Collaborators

5 joint publications

Nia Adeniji

4 joint publications

Dean W Felsher

3 joint publications

Lea Lemaitre

2 joint publications

Craig Lammert